Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S292000, C544S250000, C206S570000, C206S828000, C514S267000
Reexamination Certificate
active
06946469
ABSTRACT:
The present invention relates to 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones of formula I:or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, wherein A is selected from NCN, NCONH2, and NOR9. The present invention relates to compounds which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
REFERENCES:
patent: 5391737 (1995-02-01), Reiter et al.
patent: 5434152 (1995-07-01), Huffman et al.
patent: 5457201 (1995-10-01), Yasuda et al.
patent: 5519021 (1996-05-01), Young et al.
patent: 6124302 (2000-09-01), Corbett et al.
patent: 4320347 (1994-12-01), None
patent: 0530994 (1992-08-01), None
patent: 0582455 (1993-08-01), None
patent: 2281297 (1994-08-01), None
patent: 93/04047 (1993-03-01), None
patent: 95/12583 (1995-05-01), None
patent: 95/13273 (1995-05-01), None
Houpis et al., Synthesis of a New Generation Reverse Transcriptase Inhibitor via the BC 13/GaCI3-Induced Condensation of Anillines with Nitriles (Sugasawa Reaction), Tetrahedron Letters, 1994, pp. 6811-6814, vol. 35, No. 7.
Tucker et al., Synthesis of a Series of 4-(Arylethynyl)-6-Chloro-4-Cyclopropyl-3,4-Dihydroquinazolin-2(1H)-Ones as Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors, J. Med. Chem., 1994, pp. 2437-2444, vol. 37.
Huffman et al., Lithuum Alkoxides of Cinchona Alkaloids as Chiral Controllers for Enantioselective Acetylide Addition to Cyclic N-Acyl Ketimines, J. Org. Chem., 1995, pp. 1590-1594, vol. 60.
Erik De Clercq, “Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection”,II Farmaco, vol. 54, pp. 26-45, 1999.
Corbett Jeffery W.
Rodgers James David
Berch Mark L.
Bristol-Myers Squibb Pharma Company
VanAtten Mary
LandOfFree
Cyanamide, alkoxyamino, and urea derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyanamide, alkoxyamino, and urea derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanamide, alkoxyamino, and urea derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3376112